It promotes angiogenesis through VEGF pathway activation, modulates nitric oxide production, and produces cytoprotective effects in connective tissue, vascular endothelium, and gastrointestinal epithelium
Benefits teams working from real-time analytics are making GLP-1 formulary decisions in June that take effect while there is still time to act
As healthcare systems prioritize chronic disease management, GLP-1 receptor agonists are positioned to remain a critical component of treatment protocols
For example, research published in JAMA Network Open found that between 2018 and 2023, spending on GLP-1s increased by a whopping 500%, from $13.7 billion to $71.7 billion
As the native reference peptide for the entire GLP-1 receptor agonist drug class a research field now spanning semaglutide, liraglutide, dulaglutide, tirzepatide, and retatrutide verified, high-purity GLP-1 is an essential research tool for any laboratory conducting GLP-1R binding, signalling, or comparative pharmacology studies
The tubular hypothesis of nephron filtration and diabetic kidney disease